Navigation Links
Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
Date:2/5/2008

, single-administration, placebo-controlled study in

approximately 160 migraine patients with or without aura. Three doses

of AZ-104 (1.25, 2.5 and 5 mg) were evaluated against placebo in the

clinical trial. Using the IHS (International Headache Society) 4-point

rating scale, the primary efficacy endpoint is pain-relief response at

2 hours post-administration. Alexza expects preliminary findings to be

released by the end of Q1 2008. AZ-104 is being developed through

Symphony Allegro.

-- AZ-002 (Staccato alprazolam) is being developed for the acute treatment

of panic attacks associated with panic disorder. Alexza is conducting

a Phase 2a proof-of-concept clinical trial in panic disorder patients.

The primary aim of the in-clinic clinical trial is to assess the safety

and efficacy of a single dose of AZ-002 in treating a

pharmacologically-induced panic attack. Alexza has completed the

open-label, lead-in segment of the clinical trial, identifying the 1 mg

AZ-002 dose as an acceptable dose in terms of its safety and efficacy

profile, and has initiated the randomized, double blind,

placebo-controlled segment of the clinical trial. Alexza expects the

enrollment of this clinical trial to be completed by the end of Q2

2008. AZ-002 is being developed through Symphony Allegro.

-- AZ-003 (Staccato fentanyl) is being developed for the treatment of

breakthrough pain in cancer and non-cancer patients. In December 2007,

Alexza entered into a license and development agreement with Endo

Pharmaceuticals Holdings Inc. for development of AZ-003 and the

fentanyl class of molecules in North America. In the partnership,

Alexza has primary responsibility for the development of the Staccato

Electric Multiple Dose device and the exclusive right to manufactu
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
7. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
8. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. Prolexys Pharmaceuticals Initiates Phase 1 Study
11. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 2, 2015 ... as ,Friendly Aedes aegypti , , reduced ... Brazil by 95%, well below ...      (Logo: http://photos.prnewswire.com/prnh/20150630/227348LOGO) , The journal PLOS ... trial of Oxitec,s genetically engineered mosquitoes. The results showed ...
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/nlfg34/cancer ) has announced the ... by Application - Forecast to 2020" report to their offering. ... $13.1 Billion in 2020 from an estimated $7.1 Billion in 2015, ... dominated by North America , followed by ... of the World (RoW). The cancer diagnostics market in ...
(Date:7/2/2015)... Pharma Major Lupin Limited today announced the acquisition of ... subject to certain closing conditions. The acquisition marks ... 765 billion in sales, placing it as one of the ... Health). For over a decade, Russian pharmaceutical market recorded double ... Russia to be one of the ...
Breaking Medicine Technology:Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3
... 1, 2011 Hologic, Inc. (NASDAQ: HOLX ) ... Financial Officer, will be presenting at the Nasdaq OMX 27th ... 11:15am (GMT). Interested parties are invited to listen ... the investor section of Hologic,s website at www.hologic.com/investors-overview . ...
... Md., Dec. 1, 2011 The Food and Drug Administration ... products, including a potentially contaminated nasal spray ... unapproved drug sold as a testosterone booster ... alerts were prompted by reports FDA received from health care ...
Cached Medicine Technology:
(Date:7/3/2015)... ... 03, 2015 , ... First Choice Emergency Room , the largest network ... as the new Medical Director of its Frisco facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and ... this week that he says will reveal biblical truth and expose popular lies regarding ... Your Bible Say Don’t Have Sex”, immediately goes into the core of the subject ...
(Date:7/3/2015)... ... 2015 , ... The Celebrity Dresses is currently running a promotion through July ... will have the opportunity to get 10% discount on orders that are over $100. ... have to use coupon codes or remember redemption codes. , There is a ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its ... the Lone Star State. The premium frozen yogurt chain was listed as #22 on the ... 19 in the Village at Bachman Lake, is located at:, 3701 W. Northwest Highway, STE ...
(Date:7/2/2015)... ... ... Following the recent report by JAMA Internal Medicine published on ... Samir Becic emphatically declared a war on obesity in the United States. , "Obesity ... must understand the magnitude of this discovery. For that reason, I am declaring, along ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4
... by a jackal in Bihar's Gopalganj district, but there are ... patients. ,In the last two days, ... and children - in half a dozen villages under the ... ,The injured are being treated at different hospitals ...
... bio-technology pharma company from Zurich, Switzerland has developed a ... months at a time . ,The drug ... blood pressure by contracting vessels, by inducing antibodies. ... CYT006-AngQb developed by Cytos Biotechnology reduced systolic blood pressure ...
... in that US doctors tend to prescribe unwanted, even possibly ... the name of lecture assignments. ,Lawmakers are ... to disclose payments made to doctors and also keep within ... earn more money from drug makers than doctors in any ...
... heiress Paris Hilton under house arrest, has defended his ... from a 'life-threatening' psychiatric condition called decompensating. ... mental state to the point of severe depression, nervousness ... Simple Life star's condition was even more complicated because ...
... Louis University has found that a patient's emotional state plays ... surgery. ,After hip surgery, two tests are ... is a clinical measure of hip function given by the ... considers a wide variety of factors in determining the overall ...
... at the University of York and Hull York Medical School ... folate. ,Folate is a vitamin that comes ... and peas. Fortified cereal products, sunflower seeds as well as ... been claiming that adding folate to bread or flour will ...
Cached Medicine News:Health News:US Lawmakers Considering Legislation to Restrict Payments by Drug Companies to Doctors 2Health News:US Lawmakers Considering Legislation to Restrict Payments by Drug Companies to Doctors 3Health News:Emotions Play 'significant Role' in Recovery from Hip Surgery 2
... Get the equivalent of 7.5 liters out ... will you need two machines for your high-flow ... OXYMIZER Disposable Oxygen-Conserving Devices function like standard conservers, ... flow of oxygen required to saturate a patient. ...
Lightweight Pneumatic Conserver., ,NOTE: All models passed the ASTM PS 127-00 regulator ignition safety test....
Lightweight Pneumatic Conserver., ,NOTE: All models passed the ASTM PS 127-00 regulator ignition safety test....
... an average 5:1 increase in usage time at ... a standard cannula. , ,The combination of ... oxygen patients a superior alternative to liquid oxygen. ... , ,NOTE: Each ...
Medicine Products: